Randomized Phase III Trail of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naive Korean Patients with Extensive-Disease Small Cell Lung Cancer

Kim, DW; Kim, HG; Kim, JH; Park, K; Kim, HK; Jang, JS; Kim, BS; Kang, JH; Lee, KF; Kim, SW; Ryoo, HM; Kim, JS; Lee, KH; Kwon, JH; Choi, JH; Shin, SW; Hahn, S; Heo, DS

Heo, DS (reprint author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.

CANCER RESEARCH AND TREATMENT, 2019; 51 (1): 119

Abstract

Purpose This randomized phase III study was designed to compare the efficacy and safety of irinotecan plus cisplatin (IP) over etoposide plus cisplati......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索